KK Shah Hospitals Ltd544013Corporate

Hospital Latest results: Mar 2026 7 quarters of data

₹44.00

MCap ₹30 Cr

KK Shah Hospitals Ltd — Stock analysis & AI research KK Shah Hospitals Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹5 Cr

Sales · Mar 2026

-7.2% YoY

₹0 Cr

Operating Profit · Mar 2026

+157.1% YoY

2.6%

OPM % · Mar 2026

+161.9% YoY

₹-0 Cr

Net Profit · Mar 2026

+57.1% YoY

₹-0.44

EPS · Mar 2026

+57.3% YoY

📝 KK Shah Hospitals Ltd — results explained

Quarter ended March 2026 (Q4 FY26)

KK Shah Hospitals Ltd reported revenue of ₹5 crore for the quarter ended March 2026 (Q4 FY26), down 7.2% from ₹5 crore in the same quarter last year.

The company reported a net loss of ₹0 crore, against a net loss of ₹1 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.44.

Operating profit stood at ₹0 crore — an operating margin (OPM) of 2.6%, compared with -4.2% in the year-ago quarter.

Full year and trailing twelve months

On a trailing-twelve-month (TTM) basis, revenue stands at ₹9 crore with a net loss of ₹1 crore.

Valuation snapshot

At the current price of ₹44.00, 544013 has a market capitalisation of ₹30 crore.

Within the Hospital industry, it is the 8th-largest of the 10 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 71.36%, public shareholders 28.65% of KK Shah Hospitals Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹30 Cr

Current Price ?

₹44.0

P/E ?

N/A

Industry P/E ?

39.60

P/B ?

2.34

P/S ?

3.18

P/FCF ?

-5.08

Enterprise Value ?

₹30 Cr

EV/EBITDA ?

38.91

PEG ?

N/A

Earnings Yield ?

-3.1%

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹9 Cr

OPM ?

8.2%

Profit after tax (TTM) ?

₹-1 Cr

EPS (TTM) ?

₹-0.91

ROCE ?

-5.5%

ROE ?

-4.8%

ROA ?

-4.1%

Growth

Sales — latest qtr ?

₹5 Cr

PAT — latest qtr ?

₹-0 Cr

YoY qtr sales growth ?

-7.2%

YoY qtr profit growth ?

57.1%

Sales growth (3y) ?

65%

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹0 Cr

Debt to Equity ?

0.00

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

71.36%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

-3.1%

Return 6 months ?

33.3%

🗓️ Quarterly results (7 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026	YoY %	QoQ %
Sales	2	3	3	4	5	5	5	-7.2%	—
Operating Profit	0	0	0	0	-0	1	0	+157.1%	—
Other Income	0	0	0	0	0	0	0	-60.5%	—
Interest	0	0	0	0	0	0	0	—	—
Depreciation	0	0	0	0	1	1	1	+18.2%	—
Profit Before Tax	0	0	0	0	-0	-0	-1	-4.1%	—
Net Profit	0	0	0	0	-1	-0	-0	+57.1%	—
EPS	0.45	0.49	0.54	0.54	-1.03	-0.47	-0.44	+57.3%	—
OPM %	17.5%	11.2%	6.3%	8.2%	-4.2%	13.5%	2.6%	+161.9%	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	4.86	6.81	6.81	6.81	+0.0%
Reserves	0.23	7.28	6.61	5.98	-9.5%
Borrowings	-0.00	-0.00	-0.00	-0.00	—
Other Liabilities	0.52	0.54	2.56	2.24	-12.5%
Total Liabilities	5.61	14.63	15.98	15.03	-5.9%
Fixed Assets	1.29	1.27	7.81	6.49	-16.9%
CWIP	-0.00	0.62	-0.00	6.22	—
Investments	2.02	10.45	6.50	0.56	-91.4%
Other Assets	2.30	2.29	1.67	1.76	+5.4%
Total Assets	5.61	14.63	15.98	15.03	-5.9%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	0.55	-0.58	2.25	0.69	-69.3%
Cash from Investing Activity	-3.40	-9.02	-2.35	-0.60	+74.5%
Cash from Financing Activity	4.87	8.39	-0.34	-0.00	+100.0%
Net Cash Flow	2.02	-1.21	-0.44	0.09	+120.5%
Free Cash Flow	-0.84	-1.56	-4.67	-5.90	-26.3%
CFO/OP	149%	-83%	1,885%	90%	-95.2%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	8.65	5.91	2.51	20.13	+702.0%
Cash Conversion Cycle	8.65	5.91	2.51	20.13	+702.0%
Working Capital Days	-41.52	38.70	-58.53	-48.38	+17.3%
ROCE %	—	7.30%	-2.33%	-5.49%	-135.6%

👥 Shareholding (latest 4 periods)

Metric	Sep 2024	Mar 2025	Sep 2025	Mar 2026	% Chg
Promoters	71.36%	71.36%	71.36%	71.36%	+0.0%
Public	28.63%	28.64%	28.63%	28.65%	+0.1%
No. of Shareholders	420	392	377	362	-4.0%

⚖️ Peer comparison

Industry: Hospital · 10 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	PARKHOSPS Park Medi	₹280.90	12,133	42.4	1,756	298	26.5%	16.9%	—	—	19.3%	34.8%
2	526783 Dr Agarwals	₹5,253.00	2,465	33.3	497	75	30.4%	15.2%	18.6%	27.8%	22.2%	37.5%
3	524520 KMC Speciality	₹81.32	2,373	23.8	331	57	30.4%	17.1%	32.5%	108.7%	37.0%	107.2%
4	GKSL Gujarat Kidney	₹172.33	1,359	—	—	—	—	—	—	—	—	—
5	543346 Aashka Hospitals	₹117.80	195	83.0	23	3	22.8%	14.5%	—	—	22.3%	55.2%
6	531658 Abate As	₹28.64	120	266.9	—	2	—	—	—	158.6%	—	10.1%
7	523696 Fortis Malar	₹65.66	79	n/m	0	0	-5165.0%	427.8%	—	932.5%	-95.5%	-96.3%
8	544013 KK Shah	₹49.79	30	—	9	-1	8.2%	-6.6%	—	—	-7.2%	57.1%
9	539378 Soni Medicare	₹26.49	30	—	23	-4	-8.1%	-15.5%	-15.9%	-1405.6%	-39.2%	-313.3%
10	543520 Global Longlife	₹30.99	16	—	—	-2	—	—	—	—	—	61.5%

❓ Frequently asked questions

What was KK Shah Hospitals Ltd's revenue in Q4 FY26?